to estimate the prevalence of TaqIA, -141C and rs6280 polymorphisms of theANKK1, DRD2 and DRD3 genes and evaluate their association with theoccurrence of metabolic syndrome in patients with refractory schizophrenia. This evidence concerns the gene DRD2 and schizophrenia.